BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33902888)

  • 1. Assessment of the cut-off value of quantitative liver-portal vein contrast ratio in the hepatobiliary phase of liver MRI.
    Takatsu Y; Nakamura M; Shiozaki T; Narukami S; Yoshimaru D; Miyati T; Kobayashi S
    Clin Radiol; 2021 Jul; 76(7):551.e17-551.e24. PubMed ID: 33902888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual criterion for evaluating hepatobiliary phase image acquisition of gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid-enhanced MRI.
    Takatsu Y; Nakamura M; Kobayashi S; Miyati T
    Clin Radiol; 2018 Aug; 73(8):760.e1-760.e6. PubMed ID: 29724434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
    Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
    Eur J Radiol; 2016 Dec; 85(12):2206-2210. PubMed ID: 27842668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
    Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
    Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
    Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
    BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
    Zhang W; Wang X; Miao Y; Hu C; Zhao W
    Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method for evaluating enhancement using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid in the hepatobiliary phase of magnetic resonance imaging.
    Takatsu Y; Kobayashi S; Miyati T; Shiozaki T
    Clin Imaging; 2016; 40(6):1112-1117. PubMed ID: 27450444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Sufficient Liver Enhancement on the Gadoxetate Disodium-enhanced Hepatobiliary Phase Imaging Using Transitional Phase Images and Albumin-bilirubin Grade.
    Takatsu Y; Nakamura M; Kobayashi S; Miyati T
    Magn Reson Med Sci; 2021 Jun; 20(2):152-159. PubMed ID: 32461506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase.
    Zhang WY; Sun HY; Zhang WL; Feng R
    Sci Rep; 2023 Jan; 13(1):543. PubMed ID: 36631556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
    Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
    [No Abstract]   [Full Text] [Related]  

  • 12. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
    Cai S; Lin N; Yang Y; Ma W; Wang Y; Lin X; Wang X; Zhao X
    Eur Radiol; 2023 May; 33(5):3425-3434. PubMed ID: 36897349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of GD-EOB-DTPA-enhanced MRI: can clinical parameters predict suboptimal hepatobiliary phase?
    Kobi M; Paroder V; Flusberg M; Rozenblit AM; Chernyak V
    Clin Radiol; 2017 Jan; 72(1):55-62. PubMed ID: 27842889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
    Liu C; Shen Z; Ma H; Wang X; Wang X; Liu K; Wang X; Zhu Q; Zhao X
    Eur Radiol; 2022 May; 32(5):3006-3015. PubMed ID: 34989839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function test by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging with consideration of intrahepatic regional differences.
    Okubo H; Mogami M; Ozaki Y; Igusa Y; Aoyama T; Amano M; Kokubu S; Miyazaki A; Watanabe S
    Hepatogastroenterology; 2013 Oct; 60(127):1547-51. PubMed ID: 23933786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.